Skip to main content

Tussin CF

NDC 70677-1187 · Strategic Sourcing Services

Generic nameDextromethorphan HBr Guaifenesin Phenylephrine HCl
Dosage formSOLUTION
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
Strength20; 200; 10 mg/10mL; mg/10mL; mg/10mL
Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

70677-1187-1 — 1 BOTTLE in 1 CARTON (70677-1187-1) / 237 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70677-1050 — Guaifenesin, Dextromethorphan HBr, 70677-1051 — Guaifenesin, 70677-1052 — Guaifenesin, 70677-1054 — Guaifenesin, 70677-1055 — Dextromethorphan Hydrobromide / Guaifenesin, 70677-1056 — Guaifenesin/phenylephrine, 70677-1108 — mineral oil, petrolatum, phenylephrine HCl, 70677-1152 — Phenylephrine HCl, 70677-1185 — Dextromethorphan HBr, Guaifenesin, 70677-1186 — Guaifenesin, 70677-1257 — Guaifenesin, 70677-1258 — Guaifenesin, 70677-1259 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 70677-1261 — Dextromethorphan HBr Guaifenesin, 70677-1263 — Guaifenesin and Pseudoephedrine HCl, 70677-1272 — guaifenesin and pseudoephedrine hydrochloride, 70677-1273 — guaifenesin, pseudoephedrine hydrochloride, 70677-1287 — brompheniramine maleate, dextromethorphan hydrobromide, 70677-1291 — guaifenesin, 70677-1292 — cocoa butter, phenylephrine HCl, +3082 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels